China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

For decades, the United States has led the world in biotech and pharmaceutical innovation ... FDA guidance for pharmaceutical companies should require a cost-benefit analysis that includes ...

In recent years, Chinese investment in U.S. and global biotech and medtech has increased significantly. These partnerships ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

The US’s policy under the Second Donald Trump Administration has undergone major changes, with experts saying that America is ...

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

While MIC2025 was officially shelved from public discourse in 2018 due to intense international backlash, its core objectives ...

On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of the French Republic, HTL ...